Glucosamine Hydrochloride

Jiangsu Aoxin Biotechnology, established in 1997, manufactures chiral intermediates and antibiotic active ingredients, distributing to markets across North America, Central/South America, Western and Eastern Europe, and Asia. The company competes on brand recognition, an experienced R&D staff, production capacity, and its willingness to accommodate buyers' specifications and small orders.